View in EDS

Risankizumab is effective following ustekinumab failure in Crohn's disease: A real-world study from a tertiary center.

Saved in:
Bibliographic Details
Title: Risankizumab is effective following ustekinumab failure in Crohn's disease: A real-world study from a tertiary center.
Authors: Colwill M; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom.; Institute of Infection and Immunity, City St George's, University of London, London SW17 0RE, United Kingdom. michael.colwill@stgeorges.nhs.uk., Padley J; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom., Qazi U; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom., Mehta S; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom., Donovan F; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom., Alves AM; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom., Pollok R; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom.; Institute of Infection and Immunity, City St George's, University of London, London SW17 0RE, United Kingdom., Patel K; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom., Dawson P; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom., Honap S; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom.; School of Immunology and Microbial Sciences, King's College London, London WC2R 2LS, United Kingdom., Poullis A; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom.; Institute of Infection and Immunity, City St George's, University of London, London SW17 0RE, United Kingdom.
Source: World journal of gastrointestinal pharmacology and therapeutics [World J Gastrointest Pharmacol Ther] 2025 Dec 05; Vol. 16 (4), pp. 110273.
Publication Type: Journal Article
Journal Info: Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 101547456 Publication Model: Print Cited Medium: Print ISSN: 2150-5349 (Print) Linking ISSN: 21505349 NLM ISO Abbreviation: World J Gastrointest Pharmacol Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2150-5349
DOI:10.4292/wjgpt.v16.i4.110273